These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1064743)

  • 21. [High-dose cytosine arabinoside treatment of leukemia with special reference to the optimal number of doses].
    Sampi K; Maseki N; Kumai R; Kaneko Y; Sakurai M; Hattori M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2595-8. PubMed ID: 2774589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of cytosine arabinoside maintenance in acute nonlymphoblastic leukemia.
    Grozea PN; Bottonley RH; Shaw MT; Tu H; Chanes RE; Condit PT
    Cancer; 1975 Sep; 36(3):855-60. PubMed ID: 1182675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia.
    Hiddemann W; Kreutzmann H; Straif K; Ludwig WD; Mertelsmann R; Planker M; Donhuijsen-Ant R; Lengfelder E; Arlin Z; Büchner T
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):73-7. PubMed ID: 3473685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemia.
    Stryckmans P; De Witte T; Bitar N; Marie JP; Suciu S; Solbu G; Debusscher L; Bury J; Peetermans M; Andrien JM
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):67-72. PubMed ID: 3296209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271).
    Bodey GP; Rodriguez V; Hart J; Freireich EJ
    Cancer Chemother Rep; 1970 Aug; 54(4):255-62. PubMed ID: 4946010
    [No Abstract]   [Full Text] [Related]  

  • 26. [Intracellular retention of cytarabine-triphosphate (Ara-CTP) in blasts of children with acute lymphoblastic leukemia. Correlation with clinical course parameters].
    Schiller M; Hohenlöchter B; Schulze-Westhoff P; Zimmermann M; Ritter J; Jürgens H; Boos J
    Klin Padiatr; 1996; 208(4):151-9. PubMed ID: 8926681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of two schedules of cytosine arabinoside used in combination with adriamycin and 6-thioguanine in the treatment of acute myelogenous leukemia.
    Slevin ML; Rohatiner AZ; Dhaliwal HS; Henry GP; Bell R; Lister TA
    Med Pediatr Oncol; 1982; 10 Suppl 1():185-92. PubMed ID: 6962318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults.
    Whitecar JP; Bodey GP; Freireich EJ; McCredie KB; Hart JS
    Cancer Chemother Rep; 1972 Aug; 56(4):543-50. PubMed ID: 5081596
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug effect in acute leukemia.
    Lampkin BC; Nagao T; Mauer AM
    J Clin Invest; 1969 Jun; 48(6):1124-30. PubMed ID: 5253748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia.
    Rivera G; Dahl GV; Bowman WP; Avery TL; Wood A; Aur RJ
    Cancer; 1980 Oct; 46(8):1727-30. PubMed ID: 6932995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of arabinosyl cytosine on granulopoietic colony formation by marrow cells from leukemic and non-leukemic patients.
    Niho Y; Till JE; McCulloch EA
    Exp Hematol; 1976 Mar; 4(2):63-9. PubMed ID: 1063075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T-cell leukemia.
    Lauer SJ; Pinkel D; Buchanan GR; Sartain P; Cornet JM; Krance R; Borella LD; Casper JT; Kun LE; Hoffman RG
    Cancer; 1987 Nov; 60(10):2366-71. PubMed ID: 3499211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High dose cytosine arabinoside in the management of refractory acute leukaemia.
    Willemze R; Zwaan FE; Colpin G; Keuning JJ
    Scand J Haematol; 1982 Aug; 29(2):141-6. PubMed ID: 6958004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose cytosine arabinoside-induced remission of lymphoblastic leukemia in a cat.
    Helfand SC
    J Am Vet Med Assoc; 1987 Sep; 191(6):707-10. PubMed ID: 2824412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased survival in childhood acute nonlymphocytic leukemia after treatment with prednisone, cytosine arabinoside, 6-thioguanine, cyclophosphamide, and oncovin (PATCO) combination chemotherapy.
    Chard RL; Finklestein JZ; Sonley MJ; Nesbit M; McCreadie S; Weiner J; Sather H; Hammond GD
    Med Pediatr Oncol; 1978; 4(3):263-73. PubMed ID: 355821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia.
    Keating MJ; Smith TL; McCredie KB; Bodey GP; Hersh EM; Gutterman JU; Gehan E; Freireich EJ
    Cancer; 1981 Jun; 47(12):2779-88. PubMed ID: 6942906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric determination with bromodeoxyuridine/DNA assay of sensitivity of S-phase cells to cytosine arabinoside in childhood acute lymphoblastic leukemia.
    Katano N; Tsurusawa M; Niwa M; Fujimoto T
    Am J Pediatr Hematol Oncol; 1989; 11(4):411-6. PubMed ID: 2618975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maintenance of remission in adult acute nonlymphoblastic leukemia using intermittent courses of cytosine arabinoside (NSC-63878) and 6-thioguanine (NSC-752).
    Armitage JO; Burns CP
    Cancer Treat Rep; 1976 May; 60(5):585-9. PubMed ID: 991147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent childhood lymphocytic leukemia: clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission.
    Rivera G; Murphy SB; Aur RJ; Verzosa MS; Dahl GV; Mauer AM
    Cancer; 1978 Dec; 42(6):2521-8. PubMed ID: 282003
    [No Abstract]   [Full Text] [Related]  

  • 40. Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia.
    Winter JN; Variakojis D; Gaynor ER; Larson RA; Miller KB
    Cancer; 1985 Aug; 56(3):443-9. PubMed ID: 3859362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.